ArticleInternational journal of general medicine2025
Serum Metallome Features and Their Effects on Chronic Kidney Disease: A Comparative Study.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Epidemiological evidence links exposure to certain metals with decreased kidney function and kidney disease progression. This study investigates the metallome profiles in chronic kidney disease (CKD) patients and their relationship to disease onset and progression. Methods: A total of 341 CKD patients (CKD group) and 60 healthy controls (HC group) were recruited. Renal function markers, including urea, creatinine (Creat), uric acid (UA), cystatin C (CysC), and complement component 1q (C1q), along with the levels of 26 metal elements, were assessed to examine the relationship between metal element concentrations and renal function markers. Results: Compared to the HC group, serum concentrations of Li, Mg, Al, Ca, V, Mn, Ni, Cu, Ga, Se, Rb, Mo, Sn, Cs, and Pb were elevated in CKD patients (all Conclusion: CKD patients exhibit altered serum levels of various metals. Al, V, Co, Ga, Cs, and Pb are linked to CKD onset, while Li, V, Mo, and Cs relate to its progression. These findings suggest that monitoring specific metal elements like V, Pb and Mo could aid in early CKD detection and progression assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.